556 related articles for article (PubMed ID: 18407917)
1. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
Cateau E; Rodier MH; Imbert C
J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
[TBL] [Abstract][Full Text] [Related]
2. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone.
Cateau E; Berjeaud JM; Imbert C
Int J Antimicrob Agents; 2011 Apr; 37(4):380-4. PubMed ID: 21353488
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
Seidler M; Salvenmoser S; Müller FM
Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
[TBL] [Abstract][Full Text] [Related]
4. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
5. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
Toulet D; Debarre C; Imbert C
J Antimicrob Chemother; 2012 Feb; 67(2):430-2. PubMed ID: 22081268
[TBL] [Abstract][Full Text] [Related]
6. Micafungin is more active against Candida albicans biofilms with high metabolic activity.
Marcos-Zambrano LJ; Escribano P; González del Vecchio M; Bouza E; Guinea J
J Antimicrob Chemother; 2014 Nov; 69(11):2984-7. PubMed ID: 24942468
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
[TBL] [Abstract][Full Text] [Related]
8. An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans - Staphyloccoccus aureus Biofilms.
Lown L; Peters BM; Walraven CJ; Noverr MC; Lee SA
PLoS One; 2016; 11(7):e0159225. PubMed ID: 27428310
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to echinocandins in Candida albicans: case report and review.
Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA
Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
[TBL] [Abstract][Full Text] [Related]
13. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
14. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
Lazzell AL; Chaturvedi AK; Pierce CG; Prasad D; Uppuluri P; Lopez-Ribot JL
J Antimicrob Chemother; 2009 Sep; 64(3):567-70. PubMed ID: 19584104
[TBL] [Abstract][Full Text] [Related]
17. Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses.
Kaneko Y; Ohno H; Fukazawa H; Murakami Y; Imamura Y; Kohno S; Miyazaki Y
Med Mycol; 2010 Jun; 48(4):606-12. PubMed ID: 19958255
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
19. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution.
Balestrino D; Souweine B; Charbonnel N; Lautrette A; Aumeran C; Traoré O; Forestier C
Nephrol Dial Transplant; 2009 Oct; 24(10):3204-9. PubMed ID: 19383833
[TBL] [Abstract][Full Text] [Related]
20. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
